GB9305510D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9305510D0
GB9305510D0 GB939305510A GB9305510A GB9305510D0 GB 9305510 D0 GB9305510 D0 GB 9305510D0 GB 939305510 A GB939305510 A GB 939305510A GB 9305510 A GB9305510 A GB 9305510A GB 9305510 D0 GB9305510 D0 GB 9305510D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB939305510A
Other versions
GB2276164A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB9305510A priority Critical patent/GB2276164A/en
Publication of GB9305510D0 publication Critical patent/GB9305510D0/en
Publication of GB2276164A publication Critical patent/GB2276164A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9305510A 1993-03-17 1993-03-17 Aniline and benzanilide derivatives Withdrawn GB2276164A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9305510A GB2276164A (en) 1993-03-17 1993-03-17 Aniline and benzanilide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9305510A GB2276164A (en) 1993-03-17 1993-03-17 Aniline and benzanilide derivatives

Publications (2)

Publication Number Publication Date
GB9305510D0 true GB9305510D0 (en) 1993-05-05
GB2276164A GB2276164A (en) 1994-09-21

Family

ID=10732231

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9305510A Withdrawn GB2276164A (en) 1993-03-17 1993-03-17 Aniline and benzanilide derivatives

Country Status (1)

Country Link
GB (1) GB2276164A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326008D0 (en) * 1993-12-21 1994-02-23 Smithkline Beecham Plc Novel compounds
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
HUP9902341A2 (en) 1995-12-29 1999-10-28 Boehringer Ingelheim (Canada) Ltd. Phenyl thiazole derivatives with anti herpes virus properties, preparation and use thereof, pharmaceutical compositions containing these compounds
JP2001506995A (en) * 1996-12-19 2001-05-29 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー N-piperazin-1-ylphenyl-benzamide derivatives
JP5592265B2 (en) * 2007-11-01 2014-09-17 アキュセラ インコーポレイテッド Amine derivative compounds for the treatment of eye diseases and disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
GB2276164A (en) 1994-09-21

Similar Documents

Publication Publication Date Title
GB9304618D0 (en) Chemical compounds
GB9301000D0 (en) Chemical compounds
GB9312210D0 (en) Chemical compounds
GB9311682D0 (en) Chemical compounds
GB9305468D0 (en) Chemical compounds
GB9310635D0 (en) Chemical compounds
GB9305469D0 (en) Chemical compounds
GB2280677B (en) Chemical compounds
GB9308421D0 (en) Chemical compounds
GB9305509D0 (en) Chemical compounds
GB9307749D0 (en) Chemical compounds
GB9305523D0 (en) Chemical compounds
GB9305510D0 (en) Chemical compounds
GB9305806D0 (en) Chemical compounds
GB9306941D0 (en) Chemical compounds
GB9303987D0 (en) Chemical compounds
GB9307806D0 (en) Chemical compounds
GB9308419D0 (en) Chemical compounds
GB9307809D0 (en) Chemical compounds
GB9308422D0 (en) Chemical compounds
GB9309718D0 (en) Chemical compounds
GB9304530D0 (en) Chemical compounds
GB9304499D0 (en) Chemical compounds
GB9304640D0 (en) Chemical compounds
GB9304641D0 (en) Chemical compounds

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)